Dr. Cuiping Zhou | Swift Diagnosis Award | Best Researcher Award

Posted on by ScienceFather

Dr. Cuiping Zhou | Swift Diagnosis Award | Best Researcher Award

Dr. Cuiping Zhou, Southern Medical University, China

Cuiping Zhou, a prominent medical practitioner and researcher based at Nanfang Hospital, Southern Medical University, has dedicated her career to revolutionizing emergency medicine through cutting-edge nanotechnology. Holding an MD in Clinical Medicine from Southern Medical University, she pursued postdoctoral training at Nanfang Hospital before embarking on a transformative journey as a Visiting Scholar at Harvard Medical School. Zhou’s groundbreaking research has garnered international acclaim, notably in the development of graphene microchips for rapid pathogen detection and wearable fluorescent mouthguards for dental lesion visualization. With a focus on merging nanosensors with medicine, Zhou’s innovative approach is poised to revolutionize diagnostics and patient care, epitomizing her commitment to saving lives through timely interventions.

Professional Profile: 

Scopus

📚 Education:

Cuiping Zhou attained his M.D. in Clinical Medicine through the rigorous 8-year Medical Doctor’s Degree Program at Southern Medical University in Guangzhou, China. This comprehensive program equipped him with a deep understanding of clinical practice and medical research, laying a strong foundation for his subsequent contributions to the field of emergency medicine and nanotechnology integration.

👨‍⚕️ Work Experience:

Cuiping Zhou’s career trajectory in emergency medicine has been marked by significant milestones. Starting as a Resident in Emergency Medicine at Nanfang Hospital, Southern Medical University in Guangzhou, China, he gained invaluable clinical experience and expertise. This was further enhanced during his tenure as a Visiting Scholar in Bioengineering Medicine at Harvard Medical School, Boston, U.S.A., where he collaborated on cutting-edge research initiatives. Returning to Nanfang Hospital as an Attending Physician in Emergency Medicine, Cuiping Zhou continues to apply his knowledge and skills to provide high-quality care to patients while actively contributing to advancements in the field

🔍 Research Focus:

Cuiping Zhou is at the forefront of pioneering research, focusing on the integration of nanosensors and medicine to revolutionize rapid diagnosis and tissue modeling of diseases. His notable contributions include the development of ultrafast detection microchips, enabling swift and accurate diagnosis. Additionally, he has innovated transparent wearable fluorescent mouthguards, providing high-sensitive visualization of dental lesions, thus advancing early detection and treatment in dentistry. Through his groundbreaking work, Cuiping Zhou continues to redefine diagnostic capabilities, offering promising solutions for improved healthcare outcomes.

Publication Top Notes:

  1. Association Analysis of Colorectal Cancer Susceptibility Variants with Gastric Cancer in a Chinese Han Population”
    • Authors: C.-P. Zhou, H.-Z. Pan, F.-X. Li, M. Li, X.-X. Yang
    • Published in Genetics and Molecular Research, 2014, Volume 13(2), Pages 3673–3680
    • This study examines the association between susceptibility variants linked to colorectal cancer and their potential relevance to gastric cancer in the Chinese Han population.
  2. “Association of Genetic Polymorphisms at 1q22 but not 10q23 with Gastric Cancer in a Southern Chinese Population”
    • Authors: X.-X. Yang, F.-X. Li, C.-P. Zhou, Y.-S. Wu, M. Li
    • Published in Asian Pacific Journal of Cancer Prevention, 2012, Volume 13(6), Pages 2519–2522
    • This research focuses on the association between specific genetic polymorphisms, particularly at 1q22, and gastric cancer susceptibility in a southern Chinese population.

 

 

 

 

Dr. KOUSALYA LAVUDI | Cancer Nanotechnology Award | Best Researcher Award

Posted on by ScienceFather

Dr. KOUSALYA LAVUDI | Cancer Nanotechnology Award | Best Researcher Award

Dr. KOUSALYA LAVUDI, Ohio State University, United States

Dr. Kousalya Lavudi, a dedicated oncology and cancer biology researcher, holds a Ph.D. from KIIT University, India, and The Ohio State University, USA. Her doctoral thesis focused on the role of Aldehyde dehydrogenase 1A1 in ovarian cancer and PARP inhibitor resistance. With a keen interest in translational research, Dr. Lavudi has contributed significantly to understanding and combating life-threatening diseases. She has a rich academic background, including a Master’s in Biotechnology and a Bachelor’s in Biology, coupled with teaching experience in biology and English. Dr. Lavudi’s research spans from green synthesis of nanoparticles to genetically engineered mouse models of pancreatic cancer. She has presented her work at esteemed conferences like AACR and has garnered awards for academic excellence throughout her career.

Professional Profile:

Scopus

Orcid 

Google Scholar

🎓 Education:

Dr. Kousalya Lavudi holds a Ph.D. in Oncology and Cancer Biology from KIIT University and The Ohio State University. She completed her Bachelor of Education (B.Ed.) in Biology at Andhra University, followed by a Master of Science (M.Sc.) in Biotechnology from Pondicherry University. Prior to her doctoral studies, Dr. Lavudi earned a Bachelor of Science (B.Sc.) in Biotechnology from Andhra University. Her diverse educational background provides her with a solid foundation for her research endeavors in the field of oncology and cancer biology.

💼 Work/Research Experience:

Dr. Kousalya Lavudi serves as a Visiting Research Fellow and current Research Associate at The Ohio State University, focusing on radiation oncology. Her role involves cutting-edge research aimed at advancing cancer treatment methods. Prior to her research position, Dr. Lavudi contributed to academia as a Lecturer in Biology at Sri Chaitanya Educational Institutions, where she played a vital role in educating and mentoring students, instilling in them both theoretical understanding and practical skills in the field of biology.

🏅 Awards & Achievements:

Dr. Kousalya Lavudi achieved remarkable academic success early on, securing the first position in her district during her 10th-grade examinations. During her undergraduate studies, she continued to excel, topping her university. Her dedication and aptitude in biotechnology were further recognized through notable achievements, including qualifying in the GATE Life Sciences examination and successfully clearing both the APSET and CSIR-LS examinations. These accomplishments underscore her exceptional academic prowess and commitment to excellence in her field.

Publication Top Notes:

  1. “Cytotoxic potential of biogenic zinc oxide nanoparticles synthesized from Swertia chirayita leaf extract on colorectal cancer cells” (2021)
    • Journal: Frontiers in Bioengineering and Biotechnology
    • Cited by: 26
  2. “Green synthesis of silver nanoparticles by leaf extracts of Boerhavia erecta and spectral characterization and their antimicrobial, antioxidant, and cytotoxic studies on ovarian …” (2020)
    • Journal: Letters in Applied NanoBioScience
    • Cited by: 19
  3. “A novel estrogen receptor β agonist diminishes ovarian cancer stem cells via suppressing the epithelial-to-mesenchymal transition” (2022)
    • Journal: Cancers
    • Cited by: 11
  4. “ERK inactivation enhances stemness of NSCLC cells via promoting Slug-mediated epithelial-to-mesenchymal transition” (2022)
    • Journal: Theranostics
    • Cited by: 10
  5. “A bioinformatic approach of targeting SARS-CoV-2 replication by silencing a conserved alternative reserve of the orf8 gene using host miRNAs” (2022)
    • Journal: Computers in Biology and Medicine
    • Cited by: 8